EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Antiproliferative and Apoptotic Assessment of Triazole‐Tethered Bisnaphthalimide‐Isatin Hybrids on Triple‐Negative Breast and Prostate Cancers

Preeti, Asif Raza, Garima Arora, Amit Anand, Arun K Sharma, Vipan Kumar iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Preeti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Guru Nanak Dev University, Amritsar, Punjab, 143005, India. Hauptthemen laut MEDLINE: Naphthalimides, Triazoles, Apoptosis, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: DST-FIST, Khalsa College, Amritsar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reports the design, synthesis, and biological evaluation of 1H‐1,2,3‐triazole‐tethered bisnaphthalimide‐isatin hybrids as potential antiproliferative agents. The compounds are efficiently synthesized via copper‐promoted azide–alkyne cycloaddition and assayed against triple‐negative breast (MDA‐MB‐231) and prostate (DU‐145) cancer cell lines. Structure–activity relationship studies reveal that halogen substitution and spacer length substantially influenced anticancer activity. The bisnaphthalimide‐isatin hybrid featuring dibromo substitution and a propyl linker demonstrates IC 50 values of 3.3 ± 0.1 μM (DU‐145) and 4.4 ± 0.3 μM (MDA‐MB‐231), comparable to clinical drugs cisplatin and 5‐fluorouracil. Notably, it exhibits favorable selectivity indices (2.07–2.76) against cancer versus normal keratinocytes (HaCaT). Mechanistic investigations establish that it induces caspase‐mediated apoptosis and molecular docking studies confirmed its strong interaction with DNA topoisomerase II (docking score: −4.894), comparable to doxorubicin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthalimidesTriazolesApoptosisAntineoplastic AgentsDrug DesignTriple Negative Breast NeoplasmsIsatinHumansCell ProliferationStructure-Activity RelationshipDrug Screening Assays, AntitumorMaleProstatic NeoplasmsMolecular Docking SimulationCell Line, TumorMolecular StructureDose-Response Relationship, DrugFemale

Stichwörter der Autor:innen

DNA topoisomerase II inhibitorsantiproliferativeapoptosisclick reactionisatintriazole

Substanzen

NaphthalimidesTriazolesAntineoplastic AgentsIsatin

Autor:innen und Institutionen

  • Department of Chemistry, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.
  • Department of Molecular and Precision Medicine, Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.
  • Department of Chemistry, Khalsa College, Amritsar, 143005, India.

ORCID-Profile: Vipan Kumar

Förderung

  • DST-FIST
  • Khalsa College, Amritsar

Zitieren

APA

Preeti, Raza, A., Arora, G., Anand, A., Sharma, A. K., & Kumar, V. (2025). Design, Synthesis, and Antiproliferative and Apoptotic Assessment of Triazole‐Tethered Bisnaphthalimide‐Isatin Hybrids on Triple‐Negative Breast and Prostate Cancers. ChemMedChem. https://doi.org/10.1002/cmdc.202500415

Vancouver

Preeti, Raza A, Arora G, Anand A, Sharma AK, Kumar V. Design, Synthesis, and Antiproliferative and Apoptotic Assessment of Triazole‐Tethered Bisnaphthalimide‐Isatin Hybrids on Triple‐Negative Breast and Prostate Cancers. ChemMedChem. 2025. doi:10.1002/cmdc.202500415

BibTeX
@article{Preeti2025,
  author = {Preeti and Raza, Asif and Arora, Garima and Anand, Amit and Sharma, Arun K and Kumar, Vipan},
  title = {Design, Synthesis, and Antiproliferative and Apoptotic Assessment of Triazole‐Tethered Bisnaphthalimide‐Isatin Hybrids on Triple‐Negative Breast and Prostate Cancers},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500415}
}
Kostenlos starten →